if semaglutide didn't work will tirzepatide 7 Reasons You Aren't Losing Weight on Weight Loss Drugs Why Weight Loss Injections Don't

Novo Nordisk is buying three Catalent facilities for $11bn in a bid to resolve supply issues holding back growth of Ozempic for diabetes and obesity therapy Wegovy.

Ozempic and other glucagon-like peptide-1 (GLP-1) agonists are a transformative new class of medicines for the treatment of diabetes and obesity, while also delivering other health benefits, such as lowering the risks of heart and kidney problems.

Holly Lofton from New York University's Langone...

Pressure for greater regulation of weight-loss injections that have been bought online is growing after at least 16 users were treated at hospital for side effects

However, further research is needed to fully understand how these therapies exert their effect on body weight and in the last section we cover open questions about the potential mechanisms of multiagonist drugs, and the understanding of how gutbrain communication can be leveraged to achieve sustained body weight loss without adverse effects.

Get updates on the Wegovy vision loss lawsuit and the connection to blurry vision and NAION